Literature DB >> 9131253

Pharmacology of neurotrophic factors.

F Hefti1.   

Abstract

The field of neurotrophic factor pharmacology emerged during the past decade with the discovery that these proteins can counteract neuronal atrophy and death in the adult nervous system. These concepts are being tested in clinical trials. Therapeutic use of neurotrophic proteins seems practical for diseases of the peripheral nervous system (PNS), where they can be given by systemic administration. For diseases of the CNS, special administration strategies will have to be developed to deliver the neurotrophic factors into the brain. The development of small molecule mimetics represents an alternative approach that is actively pursued to provide brain-penetrant neurotrophics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131253     DOI: 10.1146/annurev.pharmtox.37.1.239

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  26 in total

1.  Nerve growth factor differentially affects spatial and recognition memory in aged rats.

Authors:  G Niewiadomska; M Baksalerska-Pazera; A Gasiorowska; A Mietelska
Journal:  Neurochem Res       Date:  2006-11-17       Impact factor: 3.996

2.  Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A.

Authors:  Marco Berrera; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

Review 3.  Neuroprotection in experimental stroke with targeted neurotrophins.

Authors:  Dafang Wu
Journal:  NeuroRx       Date:  2005-01

4.  Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.

Authors:  W M Pardridge; D Wu; T Sakane
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

5.  Enantioselective total synthesis of (-)-jiadifenolide.

Authors:  Jing Xu; Lynnie Trzoss; Weng K Chang; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2011-03-11       Impact factor: 15.336

6.  Enantioselective synthesis of (-)-jiadifenin, a potent neurotrophic modulator.

Authors:  Lynnie Trzoss; Jing Xu; Michelle H Lacoske; William C Mobley; Emmanuel A Theodorakis
Journal:  Org Lett       Date:  2011-08-03       Impact factor: 6.005

Review 7.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

8.  Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues.

Authors:  Maria Carolina O Rodrigues; Dmitriy Dmitriev; Antonio Rodrigues; Loren E Glover; Paul R Sanberg; Julie G Allickson; Nicole Kuzmin-Nichols; Naoki Tajiri; Kazutaka Shinozuka; Svitlana Garbuzova-Davis; Yuji Kaneko; Cesar V Borlongan
Journal:  Interv Med Appl Sci       Date:  2012-06

9.  Concise total syntheses of the Lycopodium alkaloids (+/-)-nankakurines A and B via luciduline.

Authors:  Xiayun Cheng; Stephen P Waters
Journal:  Org Lett       Date:  2010-01-15       Impact factor: 6.005

10.  Illicium sesquiterpenes: divergent synthetic strategy and neurotrophic activity studies.

Authors:  Lynnie Trzoss; Jing Xu; Michelle H Lacoske; William C Mobley; Emmanuel A Theodorakis
Journal:  Chemistry       Date:  2013-03-22       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.